Table 1 Clinicopathological characteristics of type I and type II ovarian cancer
| Ā | All patients | Type I | Type II | |||
|---|---|---|---|---|---|---|
n | Percent | n | Percent | n | Percent | |
Total | 11,275 | NA | 3522 | 31.2% | 7753 | 68.8% |
Age (year) | ||||||
ā<ā50 | 3174 | 28.2% | 1376 | 39.1% | 1798 | 23.2% |
āā„ā50 | 8101 | 71.8% | 2146 | 60.9% | 5955 | 76.8% |
Tumor Stage | ||||||
āStage T1 | 4360 | 38.7% | 2397 | 68.1% | 1963 | 25.3% |
āStage T2 | 1727 | 15.3% | 441 | 12.5% | 1286 | 16.6% |
āStage T3 | 4658 | 41.3% | 606 | 17.2% | 4052 | 52.3% |
āStage TxM1 | 482 | 4.3% | 60 | 1.7% | 422 | 5.4% |
āUnknown | 48 | 0.4% | 18 | 0.5% | 30 | 0.4% |
Tumor size | ||||||
āā¤ā5Ā cm | 1795 | 15.9% | 535 | 15.2% | 1260 | 16.2% |
ā5-10Ā cm | 2553 | 22.6% | 662 | 18.8% | 1891 | 24.4% |
ā10-15Ā cm | 2200 | 19.5% | 736 | 20.9% | 1464 | 18.9% |
ā15-20Ā cm | 1034 | 9.2% | 452 | 12.8% | 582 | 7.5% |
ā>ā20Ā cm | 628 | 5.6% | 367 | 10.4% | 261 | 3.4% |
āUnknown | 3065 | 27.2% | 770 | 21.9% | 2295 | 29.6% |